Global Nuclear Medicine Market Analysis & Trends - Industry Forecast to 2025

  • ID: 3734910
  • Report
  • Region: Global
  • 158 pages
  • Accuray Research LLP
1 of 4
The Global Nuclear Medicine Market Poised to Grow at a CAGR of Around 8.4% Over the Next Decade to Reach Approximately $18 Billion by 2025

FEATURED COMPANIES

  • Bayer Healthcare
  • Bracco Imaging S.P.A
  • Cardinal Health
  • GE Healthcare
  • IBA Molecular Imaging
  • Mediso Ltd.,
  • MORE
The Global Nuclear Medicine is poised to grow at a CAGR of around 10.2% over the next decade to reach approximately $11.3 billion by 2025. Some of the prominent trends that the market is witnessing include rising incidence and occurrence of cancer and cardiac ailments, recent advancements in radiotracers, adoption of radiopharmaceuticals in neurological applications, recent technological developments of nuclear medicine and growth opportunities/investment opportunities.

As per application the market is classified into therapeutic applications and diagnostic applications. Therapeutic applications are further divided by endocrine tumors, bone metastasis, thyroid, lymphoma, neurology, cardiology, nephrology and other therapeutic applications. Additionally Diagnostic Applications are divided into positron emission tomography (pet) applications and single photon emission computed tomography (spect) applications.

Based on procedural volume the market is segment into therapeutic procedures and diagnostic procedures. Additionally, Therapeutic procedures are divided into brachytherapy isotopes, beta emitters and alpha emitters. Diagnostic procedures are further divided into positron emission tomography (PET) radiopharmaceuticals and single photon emission computed tomography (SPECT) radiopharmaceuticals.

By end-user the market is divided into academic research institutes, industries and medical. Additionally, Medical segment is divided into diagnostic centers and hospitals.

As per type the market is segmented into therapeutic nuclear medicine/radiopharmaceuticals and diagnostic nuclear medicine/radiopharmaceuticals. Therapeutic Nuclear Medicine/Radiopharma

This industry report analyzes the market estimates and forecasts for all the given segments on global as well as regional levels presented in the research scope. The study provides historical market data for 2013, 2014 revenue estimations are presented for 2015 and forecasts from 2016 till 2025. The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. With comprehensive market assessment across the major geographies such as North America, Europe, Asia Pacific, Middle East, Latin America and Rest of the world the report is a valuable asset for the existing players, new entrants and the future investors.

The study presents detailed market analysis with inputs derived from industry professionals across the value chain. A special focus has been made on 23 countries such as U.S., Canada, Mexico, U.K., Germany, Spain, France, Italy, China, Brazil, Saudi Arabia, South Africa, etc. The market data is gathered from extensive primary interviews and secondary research. The market size is calculated based on the revenue generated through sales from all the given segments and sub segments in the research scope. The market sizing analysis includes both top-down and bottom-up approaches for data validation and accuracy measures.

This report provides data tables, includes charts and graphs for visual analysis.

Regional Analysis:

North America
- US
- Canada
- Mexico

Europe
- France
- Germany
- Italy
- Spain
- UK
- Rest of Europe

Asia Pacific
- China
- Japan
- India
- Australia
- New Zealand
- Rest of Asia

Middle East
- Saudi Arabia
- UAE
- Rest of Middle East

Latin America
- Argentina
- Brazil
- Rest of Latin America

Rest of the World
- Africa
- Caribbean

Report Highlights:

- The report provides a detailed analysis on current and future market trends to identify the investment opportunities
- Market forecasts till 2025, using estimated market values as the base numbers
- Key market trends across the business segments, Regions and Countries
- Key developments and strategies observed in the market
- Market Dynamics such as Drivers, Restraints, Opportunities and other trends
- In-depth company profiles of key players and upcoming prominent players
- Growth prospects among the emerging nations through 2025
- Market opportunities and recommendations for new investments
ceuticals are further divided into brachytherapy isotopes, beta emitters and alpha emitters. Additionally, Diagnostic Nuclear Medicine/Radiopharmaceuticals are divided into PET radiopharmaceuticals and SPECT radiopharmaceuticals.

Based on stable isotope the market is segment into carbon (C-13), nitrogen (N-15), sulphur (S-32), oxygen (O-18), deuterium (D2) and other stable isotopes.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Bayer Healthcare
  • Bracco Imaging S.P.A
  • Cardinal Health
  • GE Healthcare
  • IBA Molecular Imaging
  • Mediso Ltd.,
  • MORE
1 Market Outline
1.1 Research Methodology
1.1.1 Research Approach & Sources
1.2 Market Trends
1.3 Regulatory Factors
1.4 Application Analysis
1.5 End User Analysis
1.6 Strategic Benchmarking
1.7 Opportunity Analysis

2 Executive Summary

3 Market Overview
3.1 Current Trends
3.1.1 Rising Incidence of Cancer and Cardiac Ailments
3.1.2 Recent advancements in Radiotracers
3.1.3 Adoption of Radiopharmaceuticals in Neurological Applications
3.1.4 Recent Technological Developments of Nuclear Medicine
3.1.5 Growth Opportunities/Investment Opportunities
3.2 Drivers
3.3 Constraints
3.4 Industry Attractiveness
3.4.1 Bargaining power of suppliers
3.4.2 Bargaining power of buyers
3.4.3 Threat of substitutes
3.4.4 Threat of new entrants
3.4.5 Competitive rivalry

4 Nuclear Medicine Market, By Application
4.1 Therapeutic Applications
4.1.1 Therapeutic Applications Market Forecast to 2025 (US$ MN)
4.1.1.1 Endocrine Tumors
4..1.1.1.1 Endocrine Tumors Market Forecast to 2025 (US$ MN)
4.1.1.2 Bone Metastasis
4.1.1.2.1 Bone Metastasis Market Forecast to 2025 (US$ MN)
4.1.1.3 Thyroid
4.1.1.3.1 Thyroid Market Forecast to 2025 (US$ MN)
4.1.1.4 Lymphoma
4.1.1.4.1 Lymphoma Market Forecast to 2025 (US$ MN)
4.1.1.5 Neurology
4.1.1.5.1 Neurology Market Forecast to 2025 (US$ MN)
4.1.1.6 Cardiology
4.1.1.6.1 Cardiology Market Forecast to 2025 (US$ MN)
4.1.1.7 Nephrology
4.1.1.7.1 Nephrology Market Forecast to 2025 (US$ MN)
4.1.1.8 Other Therapeutic Applications
4.1.1.8.1 Other Therapeutic Applications Market Forecast to 2025 (US$ MN)
4.2 Diagnostic Applications
4.2.1 Diagnostic Applications Market Forecast to 2025 (US$ MN)
4.2.1.1 Positron Emission Tomography (PET) Applications
4.2.1.1.1 Positron Emission Tomography (PET) Applications Market Forecast to 2025 (US$ MN)
4.2.1.1.1.1 Neurology
4.2.1.1.1.1.1 Neurology Market Forecast to 2025 (US$ MN)
4.2.1.1.1.2 Oncology
4.2.1.1.1.2.1 Oncology Market Forecast to 2025 (US$ MN)
4.2.1.1.1.3 Cardiology
4.2.1.1.1.3.1 Cardiology Market Forecast to 2025 (US$ MN)
4.2.1.1.1.4 Inflammation
4.2.1.1.1.4.1 Inflammation Market Forecast to 2025 (US$ MN)
4.2.1.1.1.5 Other PET Applications
4.2.1.1.1.5.1 Other PET Applications Market Forecast to 2025 (US$ MN)
4.2.1.2 Single Photon Emission Computed Tomography (SPECT) Applications
4.2.1.2.1 Single Photon Emission Computed Tomography (SPECT) Applications Market Forecast to 2025 (US$ MN)
4.2.1.2.1.1 Thyroid
4.2.1.2.1.1.1 Thyroid Market Forecast to 2025 (US$ MN)
4.2.1.2.1.2 Cardiology
4.2.1.2.1.2.1 Cardiology Market Forecast to 2025 (US$ MN)
4.2.1.2.1.3 Neurology
4.2.1.2.1.3.1 Neurology Market Forecast to 2025 (US$ MN)
4.2.1.2.1.4 Oncology
4.2.1.2.1.4.1 Oncology Market Forecast to 2025 (US$ MN)
4.2.1.2.1.5 Lymphoma
4.2.1.2.1.5.1 Lymphoma Market Forecast to 2025 (US$ MN)
4.2.1.2.1.6 Nephrology
4.2.1.2.1.6.1 Nephrology Market Forecast to 2025 (US$ MN)
4.2.1.2.1.7 Inflammation
4.2.1.2.1.7.1 Inflammation Market Forecast to 2025 (US$ MN)
4.2.1.2.1.8 Gastro Intestinal
4.2.1.2.1.8.1 Gastro Intestinal Market Forecast to 2025 (US$ MN)
4.2.1.2.1.9 Other SPECT Applications
4.2.1.2.1.9.1 Other SPECT Applications Market Forecast to 2025 (US$ MN)

5 Nuclear Medicine Market, By Procedural Volume
5.1 Therapeutic Procedures
5.1.1 Therapeutic Procedures Market Forecast to 2025 (US$ MN)
5.1.1.1 Brachytherapy Isotopes
5.1.1.1.1 Brachytherapy Isotopes Market Forecast to 2025 (US$ MN)
5.1.1.2 Beta Emitters
5.1.1.2.1 Beta Emitters Market Forecast to 2025 (US$ MN)
5.1.1.3 Alpha Emitters
5.1.1.3.1 Alpha Emitters Market Forecast to 2025 (US$ MN)
5.2 Diagnostic Procedures
5.2.1 Diagnostic Procedures Market Forecast to 2025 (US$ MN)
5.2.1.1 Positron Emission Tomography (PET) Radiopharmaceuticals
5.2.1.1.1 Positron Emission Tomography (PET) Radiopharmaceuticals Market Forecast to 2025 (US$ MN)
5.2.1.2 Single Photon Emission Computed Tomography (SPECT) Radiopharmaceuticals
5.2.1.2.1 Single Photon Emission Computed Tomography (SPECT) Radiopharmaceuticals Market Forecast to 2025 (US$ MN)

6 Nuclear Medicine Market, By End User
6.1 Academic Research institutes
6.1.1 Academic Research institutes Market Forecast to 2025 (US$ MN)
6.2 Industries
6.2.1 Industries Market Forecast to 2025 (US$ MN)
6.3 Medical
6.3.1 Medical Market Forecast to 2025 (US$ MN)
6.3.1.1 Diagnostic Centers
6.3.1.1.1 Diagnostic Centers Market Forecast to 2025 (US$ MN)
6.3.1.2 Hospitals
6.3.1.2.1 Hospitals Market Forecast to 2025 (US$ MN)

7 Nuclear Medicine Market, By Type
7.1 Therapeutic Nuclear Medicine/Radiopharmaceuticals
7.1.1 Therapeutic Nuclear Medicine/Radiopharmaceuticals Market Forecast to 2025 (US$ MN)
7.1.1.1 Brachytherapy Isotopes
7.1.1.1.1 Brachytherapy Isotopes Market Forecast to 2025 (US$ MN)
7.1.1.1.1.1 Cesium-131
7.1.1.1.1.1.1 Cesium-131 Market Forecast to 2025 (US$ MN)
7.1.1.1.1.2 Iridium-192
7.1.1.1.1.2.1 Iridium-192 Market Forecast to 2025 (US$ MN)
7.1.1.1.1.3 Palladium-103
7.1.1.1.1.3.1 Palladium-103 Market Forecast to 2025 (US$ MN)
7.1.1.1.1.4 Iodine-125
7.1.1.1.1.4.1 Iodine-125 Market Forecast to 2025 (US$ MN)
7.1.1.1.1.5 Other Brachytherapy Isotopes
7.1.1.1.1.5.1 Other Brachytherapy Isotopes Market Forecast to 2025 (US$ MN)
7.1.1.2 Beta Emitters
7.1.1.2.1 Beta Emitters Market Forecast to 2025 (US$ MN)
7.1.1.2.1.1 Lutetium-177
7.1.1.2.1.1.1 Lutetium-177 Market Forecast to 2025 (US$ MN)
7.1.1.2.1.2 Yttrium-90
7.1.1.2.1.2.1 Yttrium-90 Market Forecast to 2025 (US$ MN)
7.1.1.2.1.3 Rhenium-186
7.1.1.2.1.3.1 Rhenium-186 Market Forecast to 2025 (US$ MN)
7.1.1.2.1.4 Iodine-131
7.1.1.2.1.4.1 Iodine-131 Market Forecast to 2025 (US$ MN)
7.1.1.2.1.5 Samarium-153
7.1.1.2.1.5.1 Samarium-153 Market Forecast to 2025 (US$ MN)
7.1.1.2.1.6 Erbium (Er-169)
7.1.1.2.1.6.1 Erbium (Er-169) Market Forecast to 2025 (US$ MN)
7.1.1.2.1.7 Strontium (Sr-89)
7.1.1.2.1.7.1 Strontium (Sr-89) Market Forecast to 2025 (US$ MN)
7.1.1.2.1.8 Other Beta Emitters
7.1.1.2.1.8.1 Other Beta Emitters Market Forecast to 2025 (US$ MN)
7.1.1.3 Alpha Emitters
7.1.1.3.1 Alpha Emitters Market Forecast to 2025 (US$ MN)
7.1.1.3.1.1 Radium-223
7.1.1.3.1.1.1 Radium-223 Market Forecast to 2025 (US$ MN)
7.1.1.3.1.2 Actinium (Ac-225)
7.1.1.3.1.2.1 Actinium (Ac-225) Market Forecast to 2025 (US$ MN)
7.1.1.3.1.3 Astatine (At-211)
7.1.1.3.1.3.1 Astatine (At-211) Market Forecast to 2025 (US$ MN)
7.1.1.3.1.4 Radium-224
7.1.1.3.1.4.1 Radium-224 Market Forecast to 2025 (US$ MN)
7.1.1.3.1.5 Thorium-227 (Th-227)
7.1.1.3.1.5.1 Thorium-227 (Th-227) Market Forecast to 2025 (US$ MN)
7.1.1.3.1.6 Lead (Pb-212)/Bismuth (Bi-212)
7.1.1.3.1.6.1 Lead (Pb-212)/Bismuth (Bi-212) Market Forecast to 2025 (US$ MN)
7.1.1.3.1.7 Other Alpha Emitters
7.1.1.3.1.7.1 Other Alpha Emitters Market Forecast to 2025 (US$ MN)
7.2 Diagnostic Nuclear Medicine/Radiopharmaceuticals
7.2.1 Diagnostic Nuclear Medicine/Radiopharmaceuticals Market Forecast to 2025 (US$ MN)
7.2.1.1 PET Radiopharmaceuticals
7.2.1.1.1 PET Radiopharmaceuticals Market Forecast to 2025 (US$ MN)
7.2.1.1.1.1 Rubidium-82 (RB-82)
7.2.1.1.1.1.1 Rubidium-82 (RB-82) Market Forecast to 2025 (US$ MN)
7.2.1.1.1.2 Fluorine-18
7.2.1.1.1.2.1 Fluorine-18 Market Forecast to 2025 (US$ MN)
7.2.1.1.1.3 Gallium (Ga-68)
7.2.1.1.1.3.1 Gallium (Ga-68) Market Forecast to 2025 (US$ MN)
7.2.1.1.1.4 Fluorodeoxyglucose (FDG)
7.2.1.1.1.4.1 Fluorodeoxyglucose (FDG) Market Forecast to 2025 (US$ MN)
7.2.1.1.1.5 Other PET Radiopharmaceuticals
7.2.1.1.1.5.1 Other PET Radiopharmaceuticals Market Forecast to 2025 (US$ MN)
7.2.1.2 SPECT Radiopharmaceuticals
7.2.1.2.1 SPECT Radiopharmaceuticals Market Forecast to 2025 (US$ MN)
7.2.1.2.1.1 Gallium-67
7.2.1.2.1.1.1 Gallium-67 Market Forecast to 2025 (US$ MN)
7.2.1.2.1.2 Technetium-99m
7.2.1.2.1.2.1 Technetium-99m Market Forecast to 2025 (US$ MN)
7.2.1.2.1.3 Iodine-123
7.2.1.2.1.3.1 Iodine-123 Market Forecast to 2025 (US$ MN)
7.2.1.2.1.4 Thallium-201
7.2.1.2.1.4.1 Thallium-201 Market Forecast to 2025 (US$ MN)
7.2.1.2.1.5 Rhenium
7.2.1.2.1.5.1 Rhenium Market Forecast to 2025 (US$ MN)
7.2.1.2.1.6 Samarium
7.2.1.2.1.6.1 Samarium Market Forecast to 2025 (US$ MN)
7.2.1.2.1.7 Yttrium
7.2.1.2.1.7.1 Yttrium Market Forecast to 2025 (US$ MN)
7.2.1.2.1.8 Other SPECT Radiopharmaceuticals
7.2.1.2.1.8.1 Other SPECT Radiopharmaceuticals Market Forecast to 2025 (US$ MN)

8 Nuclear Medicine Market, By Stable Isotope
8.1 Carbon (C-13)
8.1.1 Carbon (C-13) Market Forecast to 2025 (US$ MN)
8.2 Nitrogen (N-15)
8.2.1 Nitrogen (N-15) Market Forecast to 2025 (US$ MN)
8.3 Sulphur (S-32)
8.3.1 Sulphur (S-32) Market Forecast to 2025 (US$ MN)
8.4 Oxygen (O-18)
8.4.1 Oxygen (O-18) Market Forecast to 2025 (US$ MN)
8.5 Deuterium (D2)
8.5.1 Deuterium (D2) Market Forecast to 2025 (US$ MN)
8.6 Other Stable Isotopes
8.6.1 Other Stable Isotopes Market Forecast to 2025 (US$ MN)

9 Nuclear Medicine Market, By Geography
9.1 North America
9.1.1 North America Market Forecast by Countries to 2025 (US$ MN)
9.1.1.1 US
9.1.1.2 Canada
9.1.1.3 Mexico
9.2 Europe
9.2.1 Europe Market Forecast by Countries to 2025 (US$ MN)
9.2.1.1 France
9.2.1.2 Germany
9.2.1.3 Italy
9.2.1.4 Spain
9.2.1.5 UK
9.2.1.6 Rest of Europe
9.3 Asia Pacific
9.3.1 Asia Pacific Market Forecast by Countries to 2025 (US$ MN)
9.3.1.1 China
9.3.1.2 Japan
9.3.1.3 India
9.3.1.4 Australia
9.3.1.5 New Zealand
9.3.1.6 Rest of Asia Pacific
9.4 Middle East
9.4.1 Middle East Market Forecast by Countries to 2025 (US$ MN)
9.4.1.1 Saudi Arabia
9.4.1.2 UAE
9.4.1.3 Rest of Middle East
9.5 Latin America
9.5.1 Latin America Market Forecast by Countries to 2025 (US$ MN)
9.5.1.1 Argentina
9.5.1.2 Brazil
9.5.1.3 Rest of Latin America
9.6 Rest of the World (RoW)
9.6.1 RoW Market Forecast by Countries to 2025 (US$ MN)
9.6.1.1 Africa
9.6.1.2 Caribbean

10 Key Player Activities
10.1 Mergers & Acquisitions
10.2 Partnerships, Joint Venture’s, Collaborations and Agreements
10.3 Product Launch & Expansions
10.4 Other Activities

11 Leading Companies
11.1 Bayer Healthcare
11.2 Cardinal Health
11.3 Isotec, Inc. (Sigma-Aldrich)
11.4 Advanced Accelerator Applications S.A.
11.5 Philips Healthcare
11.6 Siemens Healthcare
11.7 Medtronic, plc.
11.8 GE Healthcare
11.9 Bracco Imaging S.P.A
11.10 IBA Molecular Imaging
11.11 Fujifilm Holdings Corporation
11.12 Taiyo Nippon Sanso Corporation
11.13 Mediso Ltd.,
11.14 Cambridge Isotope Laboratories, Inc.
11.15 NTP Radioisotopes SOC Ltd.

List of Tables

Table 1 Global Nuclear Medicine Market By Region, Market Forecast (2013-2025) (US $MN)
Table 2 Global Nuclear Medicine Market By Application, Market Forecast (2013-2025) (US $MN)
Table 3 Global Nuclear Medicine Market By Therapeutic Applications, Market Forecast (2013-2025) (US $MN)
Table 4 Global Nuclear Medicine Market By Endocrine Tumors, Market Forecast (2013-2025) (US $MN)
Table 5 Global Nuclear Medicine Market By Bone Metastasis, Market Forecast (2013-2025) (US $MN)
Table 6 Global Nuclear Medicine Market By Thyroid, Market Forecast (2013-2025) (US $MN)
Table 7 Global Nuclear Medicine Market By Lymphoma, Market Forecast (2013-2025) (US $MN)
Table 8 Global Nuclear Medicine Market By Neurology, Market Forecast (2013-2025) (US $MN)
Table 9 Global Nuclear Medicine Market By Cardiology, Market Forecast (2013-2025) (US $MN)
Table 10 Global Nuclear Medicine Market By Nephrology, Market Forecast (2013-2025) (US $MN)
Table 11 Global Nuclear Medicine Market By Other Therapeutic Applications, Market Forecast (2013-2025) (US $MN)
Table 12 Global Nuclear Medicine Market By Diagnostic Applications, Market Forecast (2013-2025) (US $MN)
Table 13 Global Nuclear Medicine Market By Positron Emission Tomography (PET) Applications, Market Forecast (2013-2025) (US $MN)
Table 14 Global Nuclear Medicine Market By Single Photon Emission Computed Tomography (SPECT) Applications, Market Forecast (2013-2025) (US $MN)
Table 15 Global Nuclear Medicine Market By Procedural Volume, Market Forecast (2013-2025) (US $MN)
Table 16 Global Nuclear Medicine Market By Therapeutic Procedures , Market Forecast (2013-2025) (US $MN)
Table 17 Global Nuclear Medicine Market By Brachytherapy Isotopes, Market Forecast (2013-2025) (US $MN)
Table 18 Global Nuclear Medicine Market By Beta Emitters, Market Forecast (2013-2025) (US $MN)
Table 19 Global Nuclear Medicine Market By Alpha Emitters, Market Forecast (2013-2025) (US $MN)
Table 20 Global Nuclear Medicine Market By Diagnostic Procedures , Market Forecast (2013-2025) (US $MN)
Table 21 Global Nuclear Medicine Market By Positron Emission Tomography (PET) Radiopharmaceuticals, Market Forecast (2013-2025) (US $MN)
Table 22 Global Nuclear Medicine Market By Single Photon Emission Computed Tomography (SPECT) Radiopharmaceuticals, Market Forecast (2013-2025) (US $MN)
Table 23 Global Nuclear Medicine Market By End User, Market Forecast (2013-2025) (US $MN)
Table 24 Global Nuclear Medicine Market By Academic Research institutes, Market Forecast (2013-2025) (US $MN)
Table 25 Global Nuclear Medicine Market By Industries, Market Forecast (2013-2025) (US $MN)
Table 26 Global Nuclear Medicine Market By Medical, Market Forecast (2013-2025) (US $MN)
Table 27 Global Nuclear Medicine Market By Diagnostic Centers, Market Forecast (2013-2025) (US $MN)
Table 28 Global Nuclear Medicine Market By Hospitals, Market Forecast (2013-2025) (US $MN)
Table 29 Global Nuclear Medicine Market By Type, Market Forecast (2013-2025) (US $MN)
Table 30 Global Nuclear Medicine Market By Therapeutic Nuclear Medicine/Radiopharmaceuticals, Market Forecast (2013-2025) (US $MN)
Table 31 Global Nuclear Medicine Market By Brachytherapy Isotopes, Market Forecast (2013-2025) (US $MN)
Table 32 Global Nuclear Medicine Market By Beta Emitters, Market Forecast (2013-2025) (US $MN)
Table 33 Global Nuclear Medicine Market By Alpha Emitters, Market Forecast (2013-2025) (US $MN)
Table 34 Global Nuclear Medicine Market By Diagnostic Nuclear Medicine/Radiopharmaceuticals , Market Forecast (2013-2025) (US $MN)
Table 35 Global Nuclear Medicine Market By PET Radiopharmaceuticals, Market Forecast (2013-2025) (US $MN)
Table 36 Global Nuclear Medicine Market By SPECT Radiopharmaceuticals, Market Forecast (2013-2025) (US $MN)
Table 37 Global Nuclear Medicine Market By Stable Isotopes, Market Forecast (2013-2025) (US $MN)
Table 38 Global Nuclear Medicine Market By Carbon (C-13), Market Forecast (2013-2025) (US $MN)
Table 39 Global Nuclear Medicine Market By Nitrogen (N-15), Market Forecast (2013-2025) (US $MN)
Table 40 Global Nuclear Medicine Market By Sulphur (S-32), Market Forecast (2013-2025) (US $MN)
Table 41 Global Nuclear Medicine Market By Oxygen (O-18), Market Forecast (2013-2025) (US $MN)
Table 42 Global Nuclear Medicine Market By Deuterium (D2), Market Forecast (2013-2025) (US $MN)
Table 43 Global Nuclear Medicine Market By Other Stable Isotopes, Market Forecast (2013-2025) (US $MN)

Note: Regional tables are presented in the similar manner as the above
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Bayer Healthcare
  • Cardinal Health
  • Isotec, Inc. (Sigma-Aldrich)
  • Advanced Accelerator Applications S.A.
  • Philips Healthcare
  • Siemens Healthcare
  • Medtronic, plc.
  • GE Healthcare
  • Bracco Imaging S.P.A
  • IBA Molecular Imaging
  • Fujifilm Holdings Corporation
  • Taiyo Nippon Sanso Corporation
  • Mediso Ltd.,
  • Cambridge Isotope Laboratories, Inc.
  • NTP Radioisotopes SOC Ltd.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll